ZANETTI, ALESSANDRO REMO
 Distribuzione geografica
Continente #
EU - Europa 23.698
NA - Nord America 15.453
AS - Asia 15.319
SA - Sud America 1.309
AF - Africa 362
OC - Oceania 80
Continente sconosciuto - Info sul continente non disponibili 9
Totale 56.230
Nazione #
US - Stati Uniti d'America 14.932
GB - Regno Unito 9.599
SG - Singapore 4.682
IT - Italia 4.658
CN - Cina 4.234
DE - Germania 1.858
SE - Svezia 1.856
RU - Federazione Russa 1.832
HK - Hong Kong 1.287
VN - Vietnam 1.202
TR - Turchia 1.040
FR - Francia 968
BR - Brasile 921
UA - Ucraina 754
KR - Corea 696
IN - India 670
BD - Bangladesh 621
IE - Irlanda 609
NL - Olanda 575
FI - Finlandia 419
CA - Canada 391
EU - Europa 370
CO - Colombia 187
ID - Indonesia 178
JP - Giappone 163
PL - Polonia 105
CI - Costa d'Avorio 95
AR - Argentina 84
PK - Pakistan 83
AU - Australia 69
IQ - Iraq 65
MX - Messico 61
DK - Danimarca 57
ES - Italia 57
AT - Austria 53
BE - Belgio 52
ZA - Sudafrica 49
PH - Filippine 45
MY - Malesia 39
SA - Arabia Saudita 39
TW - Taiwan 37
EC - Ecuador 35
NO - Norvegia 35
EG - Egitto 32
IR - Iran 32
MA - Marocco 32
UZ - Uzbekistan 31
CH - Svizzera 27
KE - Kenya 27
RO - Romania 26
CL - Cile 23
GR - Grecia 23
VE - Venezuela 23
NP - Nepal 20
CZ - Repubblica Ceca 19
ET - Etiopia 19
TH - Thailandia 19
PT - Portogallo 18
AE - Emirati Arabi Uniti 17
TN - Tunisia 17
AZ - Azerbaigian 16
JO - Giordania 15
BG - Bulgaria 14
LU - Lussemburgo 14
AL - Albania 13
PY - Paraguay 13
CR - Costa Rica 12
IL - Israele 12
NG - Nigeria 12
KZ - Kazakistan 11
SN - Senegal 11
UY - Uruguay 11
DZ - Algeria 10
JM - Giamaica 10
GT - Guatemala 9
PA - Panama 9
KG - Kirghizistan 8
NZ - Nuova Zelanda 8
UG - Uganda 8
BH - Bahrain 7
BW - Botswana 7
BY - Bielorussia 7
OM - Oman 7
PE - Perù 7
RS - Serbia 7
DO - Repubblica Dominicana 6
GE - Georgia 6
LB - Libano 6
SY - Repubblica araba siriana 6
GA - Gabon 5
HN - Honduras 5
HU - Ungheria 5
LV - Lettonia 5
MK - Macedonia 5
MZ - Mozambico 5
PS - Palestinian Territory 5
BO - Bolivia 4
HR - Croazia 4
LT - Lituania 4
SI - Slovenia 4
Totale 56.500
Città #
Southend 9.078
Singapore 2.585
Chandler 1.217
Hong Kong 1.216
Seattle 1.127
Ashburn 1.024
Milan 977
San Jose 954
Beijing 920
Princeton 804
Wilmington 621
Dublin 596
Council Bluffs 551
Jacksonville 540
Redmond 509
Dallas 451
Santa Clara 428
Mountain View 401
Los Angeles 362
Lauterbourg 339
Sakarya 324
Bengaluru 321
Nanjing 302
Ho Chi Minh City 286
Fairfield 278
Des Moines 268
Boardman 258
Rome 252
Serra 250
Moscow 248
Dearborn 247
Ann Arbor 237
Hanoi 237
Houston 233
Buffalo 229
Toronto 216
Hanover 209
Guangzhou 204
Andover 201
Somerville 190
Dong Ket 187
New York 185
Woodbridge 175
Bogotá 169
Frankfurt am Main 143
Shanghai 142
Hefei 137
The Dalles 129
Saint Petersburg 126
Columbus 122
Tianjin 122
Shenyang 119
Cangzhou 114
Redwood City 106
Pisa 105
Eitensheim 101
Jinan 98
Nanchang 98
Abidjan 92
Tokyo 91
Naples 85
São Paulo 84
Warsaw 80
Hebei 75
Shenzhen 74
Berlin 73
Cambridge 73
Jakarta 72
Changsha 66
Phoenix 66
Ottawa 63
Turin 63
Florence 60
Medford 57
Seoul 56
Istanbul 53
Munich 52
Helsinki 51
Hangzhou 50
Kiez 49
Jiaxing 48
San Diego 46
Da Nang 45
Chicago 44
Fremont 44
Kunming 44
Fuzhou 41
Norwalk 40
Bitonto 38
Bologna 38
Haiphong 36
Nürnberg 34
Verona 34
Zhengzhou 34
Nuremberg 33
Lanzhou 31
Washington 31
Brussels 30
Genoa 30
Grafing 30
Totale 34.304
Nome #
Vaccinazione antinfluenzale in soggetti con cirrosi epatica cronica e trapiantati di fegato 1.286
Seroprevalence of hepatitis E virus among blood donors in northern Italy (Sondrio, Lombardy) determined by three different assays 696
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium 686
Epatite B: declino della memoria immunologica in adolescenti immunizzati con vaccini esavalenti nel primo anno di vita : sono necessari richiami per mantenere la protezione a lungo termine? 596
Hepatitis E in Italy : 5 years of national epidemiological, virological and environmental surveillance, 2012 to 2016 585
Acute hepatitis B after the implementation of universal vaccination in Italy : results from a 22-years surveillance (1993-2014) 511
Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women 337
Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in Italy 335
Strategie vaccinali per la prevenzione del rischio biologico in agricoltura e zootecnia 331
Reconstruction of the Evolutionary Dynamics of the A(H1N1)pdm09 Influenza Virus in Italy during the Pandemic and Post-Pandemic Phases 304
Analysis of a pandemic in the Italian newspapers : the A (H1N1) experience 300
Influenza and other respiratory viruses involved in severe acute respiratory disease in northern Italy during the pandemic and post pandemic period (2009-2011) 294
The immunogenicity and safety of a single 0.5mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months : Data from a randomized, Phase III study 284
Patogeni emergenti e riemergenti : un problema di sanità pubblica 280
The risk of HIV transmission by transfusion in Italy does not increase after the abolition of ban on blood donations from homosexual men 269
Immune changes in animal breeders : a pilot study conducted in northern Italy 269
Hepatitis E in Italy: a long-term prospective study 265
Occupational exposure to zoonotic agents among agricultural workers in Lombardy Region, northern Italy 262
Anti-LAV/HTLV-III antibodies in high and low risk groups 261
Molecular characterization and phylogenetic analysis of human influenza A viruses in three consecutive seasons with different epidemiological profiles 260
Reconstruction of the evolutionary dynamics of A(H3N2) influenza viruses circulating in Italy from 2004 to 2012 258
Genetic drift influenza A(H3N2) virus hemagglutinin (HA) variants originated during the last pandemic turn out to be predominant in the 2011-2012 season in Northern Italy 257
Collaborative study for the calibration of an Italian HIV RNA reference preparation against the International Standard 255
Long-lasting immunogenicity of a virosomal influenza vaccine in older children and young adults with type I diabetes mellitus 248
Epidemiological and clinical features of rotavirus among children younger than 5 years of age hospitalized with acute gastroenteritis in Northern Italy 247
Patogeni emergenti e riemergenti: un problema di sanità pubblica 242
A 2010 update on occult hepatitis B infection 242
Viability of vaccine strains in a pharmaceutical dump 240
Molecular characterization of influenza viruses circulating in Northern Italy during two seasons (2005/2006 and 2006/2007) of low influenza activity 239
Emerging and re-emerging infections at the turn of the millennium 239
Viable newcastle disease vaccine strains in a pharmaceutical dump 238
Conceptual frameworks and key dimensions to support coverage decisions for vaccines 238
Co-circulation of genetically distinct human Metapneumovirus anf human Bocavirus strains in young children with respiratory tract infections in Italy 235
Transfusion of red blood cells from an HIV-RNA-positive/anti-HIV-negative donor without HIV infection in the recipient 234
The ability of Procleix Ultrio assay to detect HBV DNA in HBsAg positive blood donors 233
Valutazione dell’immunogenicità e della persistenza dell’immunità indotta da una dose di vaccinoantinfluenzale adiuvato virosomale in bambini infetti da HIV 230
Enterovirus associated sporadic cases and epidemics 230
Seroepidemiology of HEV and HAV in two populations with different socio-economic levels and hygienic/sanitary conditions 229
Acute hepatitis A in Italy : incidence, risk factors and preventive measures 227
Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy 227
Early co-circulation of different clades of influenza A/H1N1v pandemic virus in Northern Italy 226
Long-Term Immunogenicity after One and Two Doses of a Monovalent MF59-Adjuvanted A/H1N1 Influenza Virus Vaccine Coadministered with the Seasonal 2009-2010 Nonadjuvanted Influenza Virus Vaccine in HIV-Infected Children, Adolescents, and Young Adults in a Randomized Controlled Trial 225
Immunogenicità a lungo termine di una dose di vaccino antinfluenzale adiuvato virosomale in bambini affetti da asma bronchiale 224
Chronic asymptomatic HBsAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV 224
Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy 220
Frequency of respiratory virus infections and next-generation analysis of influenza A/H1N1pdm09 dynamics in the lower respiratory tract of patients admitted to the ICU 220
Interlaboratory quality control of immunometric assays of HBsAg and anti-HBs in Italian laboratories: a two-year experience 217
Segregation of virulent influenza A(H1N1) variants in the lower respiratory tract of critically ill patients during the 2010-2011 seasonal epidemic 216
Multicenter study of the CX8 HIV RNA Quantitative Assay- A new comparative reverse transcriptase-PCR wich targets pol genomic region of HIV 1 for the measurement of Type B non type B and group O HIV-1 RNA 215
Persistence of anti-HBs antibody and immune memory 18-19 years after vaccination against hepatitis B in Italy in two cohorts of individuals primed as infants or adolescents 215
Hepatitis B vaccination of 113 hemophiliacs: lower antibody response in anti-LAV/HTLV-III-positive patients 211
Hepatitis B Vaccination: A Historical Overview with a Focus on the Italian Achievements 210
Surveillance of influenza viruses in the post-pandemic era (2010-2012) in Northern Italy 206
Hepatitis B vaccination: are escape mutant viruses a matter of concern? 206
Hepatitis C in pregnancy and mother-to-infant transmission of HCV 204
Hepatitis C virus outbreak in a haemodialysis unit: learning from failures 204
The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination 203
Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply 202
Profilo genetico ed epidemiologico dei virus influenzali circolanti in Lombardia durante le ultime tre stagioni epidemiche (2010-2013) 201
Biological risk stemming from the long-term burial of vaccinal strains 200
Hepatitis C virus infection in Italy: a multicentric seroepidemiological study : a report from the HCV study group of the Italian Association for the Study of the Liver 200
Vaccinazione anti-influenzale in una coorte di soggetti emodializzati: cross-reattività degli anticorpi vaccino-indotti con il ceppo virale epidemico nella stagione 2003/04 199
Circulating influenza virus types and subtypes in Lombardy (Italy) during the 2006/2007 season 196
Validation of a scale to measure parental psychological empowerment in the vaccination decision 196
The introduction of a NAT method of screening blood donors in Italy : a report of the first two years’ experience and a re-evaluation of residual risk 194
Challenge with a hepatitis B vaccine in two cohorts of 4–7-year-old children primed with hexavalent vaccines : An open-label, randomised trial in Italy 194
Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with Type 1 diabetes mellitus 193
Molecular characterization and phylogenetic analysis of human influenza A viruses in 3 consecutive seasons with different epidemiological profiles 192
Phylogeography and phylodynamics of European genotype 3 hepatitis E virus 192
Prevalenza di anticorpi anti-epatite E (anti-HEV) in donatori di sangue 190
Pandemic influenza vaccine in adult HIV-1-infected patients 189
Studio multicentrico e prospettico sull’infezione da HBV nei nuovi donatori in Italia 188
Status and significance of testing for hepatitis B surface antigen and surface antibody 188
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis 186
Persistenza anticorpale indotta da una dose di vaccino anti-influenzale adiuvato virosomale in bambini affetti da asma bronchiale 186
Influenza aviaria e influenza umana: esiste un rischio pandemico? 186
Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi’s sarcoma 185
Vaccination against hepatitis B: the Italian strategy. 185
Clinical, epidemiological and virological features of acute hepatitis B in Italy 185
Le vaccinazioni tra obbligo e scelta consapevole : aspetti medico-legali e giuridici 183
Valutazione della risposta anticorpale e della persistenza della memoria immunologica verso l’epatite B in coorti di bambini vaccinati con vaccini esavalenti 182
Suboptimal response to hepatitis B vaccine in drug users 182
Emerging and re-emerging viruses in the era of globalisation 181
Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users 181
A prospective study on mother-to-infant transmission of hepatitis C virus 181
Hepatitis E: a puzzling double-faced disease 179
Epidemiologia e prevenzione delle principali malattie infettive 179
Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacs 178
The worldwide impact of vaccination on the control and protection of viral hepatitis B. 177
Hepatitis delta virus infection in the world: epidemiological patterns and clinical expression 177
Il rischio residuo di trasmissione di infezioni virali con la trasfusione in Italia 176
Diffusione dell'infezione da West Nile virus nei donatori di sangue della Lombardia : risultati di due anni di osservazione 176
Caratterizzazione antigenica dell'emoagglutinina e della neuraminidasi dei ceppi di virus influenzale di tipo B isolati in Italia nel 1962, 1967 e 1971. 174
Surveillance of hepatitis A virus in urban sewages and comparison with cases notified in the course of an outbreak, Italy 2013 173
Long-term outcome (35 years) of hepatitis C in individuals who acquired infection through mini transfusions of blood given at birth 172
Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs 171
Yeast derived hepatitis B vaccine in dental students. A three-year follow-up study 171
L'infezione da West Nile Virus nei donatori di sangue in Lombardia: risultati di due anni di osservazione 171
A multicentric seroepidemiological survey of HTLV-I/II in Italy 170
Multicenter trial on mother-to-infant transmission of GBV-C virus 170
Totale 24.776
Categoria #
all - tutte 148.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021559 0 0 0 0 0 0 0 0 0 0 0 559
2021/20224.047 331 256 300 232 296 196 368 211 350 414 429 664
2022/20234.361 579 359 375 464 628 935 74 247 418 43 168 71
2023/20242.282 84 228 96 106 482 116 85 74 55 195 363 398
2024/20256.202 343 717 213 575 480 260 153 810 312 465 589 1.285
2025/202613.926 1.134 554 1.585 1.179 1.399 1.097 1.683 1.020 1.643 955 987 690
Totale 59.237